Pfizer first-quarter results miss estimates as key drug sales fall short

NEW YORK (Reuters) - Pfizer Inc on Tuesday reported lower-than-expected first-quarter revenue as demand for some key drugs and international sales fell short of estimates, sparking a 5.1 percent drop in shares of the largest U.S. drugmaker.

Pfizer first-quarter results miss estimates as key drug sales fall short
Read More


Bagikan Berita Ini